nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydromorphone—PTGS1—Etoposide—urinary bladder cancer	0.0798	0.294	CbGbCtD
Hydromorphone—CYP3A4—Thiotepa—urinary bladder cancer	0.0689	0.254	CbGbCtD
Hydromorphone—CYP2C9—Fluorouracil—urinary bladder cancer	0.0385	0.142	CbGbCtD
Hydromorphone—CYP2C9—Cisplatin—urinary bladder cancer	0.0327	0.12	CbGbCtD
Hydromorphone—CYP2D6—Doxorubicin—urinary bladder cancer	0.02	0.0738	CbGbCtD
Hydromorphone—CYP3A4—Etoposide—urinary bladder cancer	0.0187	0.0688	CbGbCtD
Hydromorphone—CYP3A4—Doxorubicin—urinary bladder cancer	0.0127	0.0469	CbGbCtD
Hydromorphone—Ethylmorphine—POR—urinary bladder cancer	0.00691	0.42	CrCbGaD
Hydromorphone—CYP2C9—urine—urinary bladder cancer	0.00478	0.123	CbGeAlD
Hydromorphone—OPRK1—prostate gland—urinary bladder cancer	0.00452	0.117	CbGeAlD
Hydromorphone—Codeine—UGT2B7—urinary bladder cancer	0.00448	0.273	CrCbGaD
Hydromorphone—UGT1A9—renal system—urinary bladder cancer	0.00406	0.105	CbGeAlD
Hydromorphone—CYP3A4—urine—urinary bladder cancer	0.00365	0.0941	CbGeAlD
Hydromorphone—Morphine—UGT2B7—urinary bladder cancer	0.00363	0.221	CrCbGaD
Hydromorphone—CYP2D6—urine—urinary bladder cancer	0.00359	0.0926	CbGeAlD
Hydromorphone—OPRD1—renal system—urinary bladder cancer	0.00321	0.0829	CbGeAlD
Hydromorphone—OPRK1—female reproductive system—urinary bladder cancer	0.00247	0.0636	CbGeAlD
Hydromorphone—PTGS1—prostate gland—urinary bladder cancer	0.00157	0.0404	CbGeAlD
Hydromorphone—Naloxone—ESR1—urinary bladder cancer	0.00142	0.0863	CrCbGaD
Hydromorphone—PTGS1—seminal vesicle—urinary bladder cancer	0.00133	0.0342	CbGeAlD
Hydromorphone—PTGS1—epithelium—urinary bladder cancer	0.00115	0.0297	CbGeAlD
Hydromorphone—PTGS1—smooth muscle tissue—urinary bladder cancer	0.00111	0.0286	CbGeAlD
Hydromorphone—PTGS1—renal system—urinary bladder cancer	0.00107	0.0276	CbGeAlD
Hydromorphone—CYP2C9—female reproductive system—urinary bladder cancer	0.000937	0.0242	CbGeAlD
Hydromorphone—CYP3A4—renal system—urinary bladder cancer	0.000892	0.023	CbGeAlD
Hydromorphone—CYP2D6—renal system—urinary bladder cancer	0.000878	0.0227	CbGeAlD
Hydromorphone—PTGS1—female reproductive system—urinary bladder cancer	0.000855	0.0221	CbGeAlD
Hydromorphone—PTGS1—vagina—urinary bladder cancer	0.000774	0.02	CbGeAlD
Hydromorphone—CYP3A4—female reproductive system—urinary bladder cancer	0.000714	0.0184	CbGeAlD
Hydromorphone—CYP2D6—female reproductive system—urinary bladder cancer	0.000703	0.0181	CbGeAlD
Hydromorphone—PTGS1—lymph node—urinary bladder cancer	0.0005	0.0129	CbGeAlD
Hydromorphone—Rhinitis—Epirubicin—urinary bladder cancer	0.000295	0.000605	CcSEcCtD
Hydromorphone—Abdominal pain—Etoposide—urinary bladder cancer	0.000295	0.000604	CcSEcCtD
Hydromorphone—Body temperature increased—Etoposide—urinary bladder cancer	0.000295	0.000604	CcSEcCtD
Hydromorphone—Eye disorder—Methotrexate—urinary bladder cancer	0.000294	0.000602	CcSEcCtD
Hydromorphone—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000294	0.000602	CcSEcCtD
Hydromorphone—Tinnitus—Methotrexate—urinary bladder cancer	0.000293	0.000601	CcSEcCtD
Hydromorphone—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000293	0.0006	CcSEcCtD
Hydromorphone—Asthenia—Cisplatin—urinary bladder cancer	0.000292	0.000599	CcSEcCtD
Hydromorphone—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000292	0.000598	CcSEcCtD
Hydromorphone—Sweating—Doxorubicin—urinary bladder cancer	0.000291	0.000596	CcSEcCtD
Hydromorphone—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000291	0.000596	CcSEcCtD
Hydromorphone—Oedema peripheral—Epirubicin—urinary bladder cancer	0.00029	0.000594	CcSEcCtD
Hydromorphone—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000289	0.000593	CcSEcCtD
Hydromorphone—Urethral disorder—Epirubicin—urinary bladder cancer	0.000289	0.000591	CcSEcCtD
Hydromorphone—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000287	0.000588	CcSEcCtD
Hydromorphone—Angiopathy—Methotrexate—urinary bladder cancer	0.000286	0.000585	CcSEcCtD
Hydromorphone—Immune system disorder—Methotrexate—urinary bladder cancer	0.000284	0.000582	CcSEcCtD
Hydromorphone—Dizziness—Fluorouracil—urinary bladder cancer	0.000284	0.000582	CcSEcCtD
Hydromorphone—Visual impairment—Epirubicin—urinary bladder cancer	0.000284	0.000581	CcSEcCtD
Hydromorphone—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000284	0.000581	CcSEcCtD
Hydromorphone—Chills—Methotrexate—urinary bladder cancer	0.000282	0.000578	CcSEcCtD
Hydromorphone—Diarrhoea—Cisplatin—urinary bladder cancer	0.000279	0.000571	CcSEcCtD
Hydromorphone—Vomiting—Gemcitabine—urinary bladder cancer	0.000278	0.000569	CcSEcCtD
Hydromorphone—Bradycardia—Doxorubicin—urinary bladder cancer	0.000277	0.000568	CcSEcCtD
Hydromorphone—Mental disorder—Methotrexate—urinary bladder cancer	0.000276	0.000565	CcSEcCtD
Hydromorphone—Rash—Gemcitabine—urinary bladder cancer	0.000276	0.000565	CcSEcCtD
Hydromorphone—Dermatitis—Gemcitabine—urinary bladder cancer	0.000275	0.000564	CcSEcCtD
Hydromorphone—Eye disorder—Epirubicin—urinary bladder cancer	0.000275	0.000564	CcSEcCtD
Hydromorphone—Hypersensitivity—Etoposide—urinary bladder cancer	0.000275	0.000563	CcSEcCtD
Hydromorphone—Tinnitus—Epirubicin—urinary bladder cancer	0.000275	0.000562	CcSEcCtD
Hydromorphone—Erythema—Methotrexate—urinary bladder cancer	0.000274	0.000561	CcSEcCtD
Hydromorphone—Malnutrition—Methotrexate—urinary bladder cancer	0.000274	0.000561	CcSEcCtD
Hydromorphone—Headache—Gemcitabine—urinary bladder cancer	0.000274	0.000561	CcSEcCtD
Hydromorphone—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000273	0.00056	CcSEcCtD
Hydromorphone—Flushing—Epirubicin—urinary bladder cancer	0.000273	0.00056	CcSEcCtD
Hydromorphone—Vomiting—Fluorouracil—urinary bladder cancer	0.000273	0.00056	CcSEcCtD
Hydromorphone—Rhinitis—Doxorubicin—urinary bladder cancer	0.000273	0.00056	CcSEcCtD
Hydromorphone—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000271	0.000555	CcSEcCtD
Hydromorphone—Rash—Fluorouracil—urinary bladder cancer	0.000271	0.000555	CcSEcCtD
Hydromorphone—Dermatitis—Fluorouracil—urinary bladder cancer	0.000271	0.000555	CcSEcCtD
Hydromorphone—Headache—Fluorouracil—urinary bladder cancer	0.000269	0.000552	CcSEcCtD
Hydromorphone—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000269	0.000551	CcSEcCtD
Hydromorphone—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000269	0.00055	CcSEcCtD
Hydromorphone—Dysgeusia—Methotrexate—urinary bladder cancer	0.000268	0.00055	CcSEcCtD
Hydromorphone—Asthenia—Etoposide—urinary bladder cancer	0.000268	0.000549	CcSEcCtD
Hydromorphone—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000268	0.000549	CcSEcCtD
Hydromorphone—Angiopathy—Epirubicin—urinary bladder cancer	0.000267	0.000547	CcSEcCtD
Hydromorphone—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000267	0.000547	CcSEcCtD
Hydromorphone—Immune system disorder—Epirubicin—urinary bladder cancer	0.000266	0.000545	CcSEcCtD
Hydromorphone—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000265	0.000544	CcSEcCtD
Hydromorphone—Back pain—Methotrexate—urinary bladder cancer	0.000265	0.000543	CcSEcCtD
Hydromorphone—Chills—Epirubicin—urinary bladder cancer	0.000264	0.000541	CcSEcCtD
Hydromorphone—Pruritus—Etoposide—urinary bladder cancer	0.000264	0.000541	CcSEcCtD
Hydromorphone—Arrhythmia—Epirubicin—urinary bladder cancer	0.000263	0.000539	CcSEcCtD
Hydromorphone—Visual impairment—Doxorubicin—urinary bladder cancer	0.000263	0.000538	CcSEcCtD
Hydromorphone—Nausea—Gemcitabine—urinary bladder cancer	0.00026	0.000532	CcSEcCtD
Hydromorphone—Vomiting—Cisplatin—urinary bladder cancer	0.000259	0.000531	CcSEcCtD
Hydromorphone—Vision blurred—Methotrexate—urinary bladder cancer	0.000258	0.000529	CcSEcCtD
Hydromorphone—Mental disorder—Epirubicin—urinary bladder cancer	0.000258	0.000529	CcSEcCtD
Hydromorphone—Rash—Cisplatin—urinary bladder cancer	0.000257	0.000526	CcSEcCtD
Hydromorphone—Dermatitis—Cisplatin—urinary bladder cancer	0.000257	0.000526	CcSEcCtD
Hydromorphone—Erythema—Epirubicin—urinary bladder cancer	0.000256	0.000525	CcSEcCtD
Hydromorphone—Malnutrition—Epirubicin—urinary bladder cancer	0.000256	0.000525	CcSEcCtD
Hydromorphone—Diarrhoea—Etoposide—urinary bladder cancer	0.000255	0.000523	CcSEcCtD
Hydromorphone—Nausea—Fluorouracil—urinary bladder cancer	0.000255	0.000523	CcSEcCtD
Hydromorphone—Eye disorder—Doxorubicin—urinary bladder cancer	0.000255	0.000522	CcSEcCtD
Hydromorphone—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000254	0.000521	CcSEcCtD
Hydromorphone—Tinnitus—Doxorubicin—urinary bladder cancer	0.000254	0.00052	CcSEcCtD
Hydromorphone—Flushing—Doxorubicin—urinary bladder cancer	0.000253	0.000518	CcSEcCtD
Hydromorphone—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000253	0.000518	CcSEcCtD
Hydromorphone—Flatulence—Epirubicin—urinary bladder cancer	0.000253	0.000517	CcSEcCtD
Hydromorphone—Tension—Epirubicin—urinary bladder cancer	0.000252	0.000515	CcSEcCtD
Hydromorphone—Dysgeusia—Epirubicin—urinary bladder cancer	0.000251	0.000514	CcSEcCtD
Hydromorphone—Nervousness—Epirubicin—urinary bladder cancer	0.000249	0.00051	CcSEcCtD
Hydromorphone—Back pain—Epirubicin—urinary bladder cancer	0.000248	0.000508	CcSEcCtD
Hydromorphone—Angiopathy—Doxorubicin—urinary bladder cancer	0.000247	0.000506	CcSEcCtD
Hydromorphone—Malaise—Methotrexate—urinary bladder cancer	0.000247	0.000506	CcSEcCtD
Hydromorphone—Dizziness—Etoposide—urinary bladder cancer	0.000247	0.000506	CcSEcCtD
Hydromorphone—Muscle spasms—Epirubicin—urinary bladder cancer	0.000247	0.000505	CcSEcCtD
Hydromorphone—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000246	0.000504	CcSEcCtD
Hydromorphone—Vertigo—Methotrexate—urinary bladder cancer	0.000246	0.000504	CcSEcCtD
Hydromorphone—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000246	0.000503	CcSEcCtD
Hydromorphone—Leukopenia—Methotrexate—urinary bladder cancer	0.000245	0.000502	CcSEcCtD
Hydromorphone—Chills—Doxorubicin—urinary bladder cancer	0.000245	0.000501	CcSEcCtD
Hydromorphone—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000243	0.000499	CcSEcCtD
Hydromorphone—Nausea—Cisplatin—urinary bladder cancer	0.000242	0.000496	CcSEcCtD
Hydromorphone—Vision blurred—Epirubicin—urinary bladder cancer	0.000242	0.000495	CcSEcCtD
Hydromorphone—Cough—Methotrexate—urinary bladder cancer	0.000239	0.00049	CcSEcCtD
Hydromorphone—Mental disorder—Doxorubicin—urinary bladder cancer	0.000239	0.000489	CcSEcCtD
Hydromorphone—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000238	0.000487	CcSEcCtD
Hydromorphone—Convulsion—Methotrexate—urinary bladder cancer	0.000237	0.000486	CcSEcCtD
Hydromorphone—Vomiting—Etoposide—urinary bladder cancer	0.000237	0.000486	CcSEcCtD
Hydromorphone—Malnutrition—Doxorubicin—urinary bladder cancer	0.000237	0.000486	CcSEcCtD
Hydromorphone—Erythema—Doxorubicin—urinary bladder cancer	0.000237	0.000486	CcSEcCtD
Hydromorphone—Agitation—Epirubicin—urinary bladder cancer	0.000236	0.000483	CcSEcCtD
Hydromorphone—Rash—Etoposide—urinary bladder cancer	0.000235	0.000482	CcSEcCtD
Hydromorphone—Dermatitis—Etoposide—urinary bladder cancer	0.000235	0.000482	CcSEcCtD
Hydromorphone—Headache—Etoposide—urinary bladder cancer	0.000234	0.000479	CcSEcCtD
Hydromorphone—Flatulence—Doxorubicin—urinary bladder cancer	0.000234	0.000479	CcSEcCtD
Hydromorphone—Chest pain—Methotrexate—urinary bladder cancer	0.000233	0.000478	CcSEcCtD
Hydromorphone—Myalgia—Methotrexate—urinary bladder cancer	0.000233	0.000478	CcSEcCtD
Hydromorphone—Arthralgia—Methotrexate—urinary bladder cancer	0.000233	0.000478	CcSEcCtD
Hydromorphone—Tension—Doxorubicin—urinary bladder cancer	0.000233	0.000477	CcSEcCtD
Hydromorphone—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000232	0.000476	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000232	0.000474	CcSEcCtD
Hydromorphone—Malaise—Epirubicin—urinary bladder cancer	0.000231	0.000474	CcSEcCtD
Hydromorphone—Discomfort—Methotrexate—urinary bladder cancer	0.00023	0.000472	CcSEcCtD
Hydromorphone—Nervousness—Doxorubicin—urinary bladder cancer	0.00023	0.000472	CcSEcCtD
Hydromorphone—Vertigo—Epirubicin—urinary bladder cancer	0.00023	0.000472	CcSEcCtD
Hydromorphone—Syncope—Epirubicin—urinary bladder cancer	0.00023	0.000471	CcSEcCtD
Hydromorphone—Leukopenia—Epirubicin—urinary bladder cancer	0.00023	0.00047	CcSEcCtD
Hydromorphone—Back pain—Doxorubicin—urinary bladder cancer	0.00023	0.00047	CcSEcCtD
Hydromorphone—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000228	0.000467	CcSEcCtD
Hydromorphone—Palpitations—Epirubicin—urinary bladder cancer	0.000227	0.000464	CcSEcCtD
Hydromorphone—Confusional state—Methotrexate—urinary bladder cancer	0.000225	0.000462	CcSEcCtD
Hydromorphone—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000225	0.000462	CcSEcCtD
Hydromorphone—Cough—Epirubicin—urinary bladder cancer	0.000224	0.000458	CcSEcCtD
Hydromorphone—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000224	0.000458	CcSEcCtD
Hydromorphone—Vision blurred—Doxorubicin—urinary bladder cancer	0.000224	0.000458	CcSEcCtD
Hydromorphone—Convulsion—Epirubicin—urinary bladder cancer	0.000222	0.000455	CcSEcCtD
Hydromorphone—Infection—Methotrexate—urinary bladder cancer	0.000222	0.000455	CcSEcCtD
Hydromorphone—Nausea—Etoposide—urinary bladder cancer	0.000222	0.000454	CcSEcCtD
Hydromorphone—Hypertension—Epirubicin—urinary bladder cancer	0.000221	0.000453	CcSEcCtD
Hydromorphone—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.00022	0.000451	CcSEcCtD
Hydromorphone—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000219	0.000449	CcSEcCtD
Hydromorphone—Myalgia—Epirubicin—urinary bladder cancer	0.000218	0.000447	CcSEcCtD
Hydromorphone—Chest pain—Epirubicin—urinary bladder cancer	0.000218	0.000447	CcSEcCtD
Hydromorphone—Arthralgia—Epirubicin—urinary bladder cancer	0.000218	0.000447	CcSEcCtD
Hydromorphone—Agitation—Doxorubicin—urinary bladder cancer	0.000218	0.000447	CcSEcCtD
Hydromorphone—Anxiety—Epirubicin—urinary bladder cancer	0.000218	0.000446	CcSEcCtD
Hydromorphone—Skin disorder—Methotrexate—urinary bladder cancer	0.000217	0.000445	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000217	0.000444	CcSEcCtD
Hydromorphone—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000216	0.000443	CcSEcCtD
Hydromorphone—Discomfort—Epirubicin—urinary bladder cancer	0.000216	0.000442	CcSEcCtD
Hydromorphone—Malaise—Doxorubicin—urinary bladder cancer	0.000214	0.000438	CcSEcCtD
Hydromorphone—Dry mouth—Epirubicin—urinary bladder cancer	0.000214	0.000437	CcSEcCtD
Hydromorphone—Vertigo—Doxorubicin—urinary bladder cancer	0.000213	0.000437	CcSEcCtD
Hydromorphone—Anorexia—Methotrexate—urinary bladder cancer	0.000213	0.000437	CcSEcCtD
Hydromorphone—Syncope—Doxorubicin—urinary bladder cancer	0.000213	0.000436	CcSEcCtD
Hydromorphone—Leukopenia—Doxorubicin—urinary bladder cancer	0.000212	0.000435	CcSEcCtD
Hydromorphone—Confusional state—Epirubicin—urinary bladder cancer	0.000211	0.000432	CcSEcCtD
Hydromorphone—Palpitations—Doxorubicin—urinary bladder cancer	0.00021	0.000429	CcSEcCtD
Hydromorphone—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000209	0.000429	CcSEcCtD
Hydromorphone—Hypotension—Methotrexate—urinary bladder cancer	0.000209	0.000428	CcSEcCtD
Hydromorphone—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000209	0.000427	CcSEcCtD
Hydromorphone—Infection—Epirubicin—urinary bladder cancer	0.000208	0.000426	CcSEcCtD
Hydromorphone—Cough—Doxorubicin—urinary bladder cancer	0.000207	0.000424	CcSEcCtD
Hydromorphone—Shock—Epirubicin—urinary bladder cancer	0.000206	0.000422	CcSEcCtD
Hydromorphone—Convulsion—Doxorubicin—urinary bladder cancer	0.000206	0.000421	CcSEcCtD
Hydromorphone—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000205	0.00042	CcSEcCtD
Hydromorphone—Hypertension—Doxorubicin—urinary bladder cancer	0.000205	0.00042	CcSEcCtD
Hydromorphone—Tachycardia—Epirubicin—urinary bladder cancer	0.000204	0.000418	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000204	0.000417	CcSEcCtD
Hydromorphone—Skin disorder—Epirubicin—urinary bladder cancer	0.000203	0.000416	CcSEcCtD
Hydromorphone—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000202	0.000414	CcSEcCtD
Hydromorphone—Insomnia—Methotrexate—urinary bladder cancer	0.000202	0.000414	CcSEcCtD
Hydromorphone—Arthralgia—Doxorubicin—urinary bladder cancer	0.000202	0.000414	CcSEcCtD
Hydromorphone—Myalgia—Doxorubicin—urinary bladder cancer	0.000202	0.000414	CcSEcCtD
Hydromorphone—Chest pain—Doxorubicin—urinary bladder cancer	0.000202	0.000414	CcSEcCtD
Hydromorphone—Anxiety—Doxorubicin—urinary bladder cancer	0.000201	0.000412	CcSEcCtD
Hydromorphone—Paraesthesia—Methotrexate—urinary bladder cancer	0.000201	0.000411	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000201	0.000411	CcSEcCtD
Hydromorphone—Discomfort—Doxorubicin—urinary bladder cancer	0.0002	0.000409	CcSEcCtD
Hydromorphone—Anorexia—Epirubicin—urinary bladder cancer	0.000199	0.000409	CcSEcCtD
Hydromorphone—Dyspnoea—Methotrexate—urinary bladder cancer	0.000199	0.000408	CcSEcCtD
Hydromorphone—Somnolence—Methotrexate—urinary bladder cancer	0.000199	0.000407	CcSEcCtD
Hydromorphone—Dry mouth—Doxorubicin—urinary bladder cancer	0.000198	0.000405	CcSEcCtD
Hydromorphone—Dyspepsia—Methotrexate—urinary bladder cancer	0.000197	0.000403	CcSEcCtD
Hydromorphone—Hypotension—Epirubicin—urinary bladder cancer	0.000196	0.0004	CcSEcCtD
Hydromorphone—Confusional state—Doxorubicin—urinary bladder cancer	0.000195	0.0004	CcSEcCtD
Hydromorphone—Decreased appetite—Methotrexate—urinary bladder cancer	0.000194	0.000398	CcSEcCtD
Hydromorphone—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000194	0.000397	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000193	0.000395	CcSEcCtD
Hydromorphone—Fatigue—Methotrexate—urinary bladder cancer	0.000193	0.000395	CcSEcCtD
Hydromorphone—Infection—Doxorubicin—urinary bladder cancer	0.000192	0.000394	CcSEcCtD
Hydromorphone—Pain—Methotrexate—urinary bladder cancer	0.000191	0.000392	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000191	0.00039	CcSEcCtD
Hydromorphone—Shock—Doxorubicin—urinary bladder cancer	0.000191	0.00039	CcSEcCtD
Hydromorphone—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.00019	0.000389	CcSEcCtD
Hydromorphone—Insomnia—Epirubicin—urinary bladder cancer	0.000189	0.000388	CcSEcCtD
Hydromorphone—Tachycardia—Doxorubicin—urinary bladder cancer	0.000189	0.000387	CcSEcCtD
Hydromorphone—Skin disorder—Doxorubicin—urinary bladder cancer	0.000188	0.000385	CcSEcCtD
Hydromorphone—Paraesthesia—Epirubicin—urinary bladder cancer	0.000188	0.000385	CcSEcCtD
Hydromorphone—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000187	0.000383	CcSEcCtD
Hydromorphone—Dyspnoea—Epirubicin—urinary bladder cancer	0.000187	0.000382	CcSEcCtD
Hydromorphone—Somnolence—Epirubicin—urinary bladder cancer	0.000186	0.000381	CcSEcCtD
Hydromorphone—Anorexia—Doxorubicin—urinary bladder cancer	0.000185	0.000378	CcSEcCtD
Hydromorphone—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000184	0.000377	CcSEcCtD
Hydromorphone—Dyspepsia—Epirubicin—urinary bladder cancer	0.000184	0.000377	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000183	0.000375	CcSEcCtD
Hydromorphone—Decreased appetite—Epirubicin—urinary bladder cancer	0.000182	0.000373	CcSEcCtD
Hydromorphone—Hypotension—Doxorubicin—urinary bladder cancer	0.000181	0.000371	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000181	0.00037	CcSEcCtD
Hydromorphone—Fatigue—Epirubicin—urinary bladder cancer	0.00018	0.00037	CcSEcCtD
Hydromorphone—Constipation—Epirubicin—urinary bladder cancer	0.000179	0.000367	CcSEcCtD
Hydromorphone—Pain—Epirubicin—urinary bladder cancer	0.000179	0.000367	CcSEcCtD
Hydromorphone—Urticaria—Methotrexate—urinary bladder cancer	0.000178	0.000364	CcSEcCtD
Hydromorphone—Abdominal pain—Methotrexate—urinary bladder cancer	0.000177	0.000362	CcSEcCtD
Hydromorphone—Body temperature increased—Methotrexate—urinary bladder cancer	0.000177	0.000362	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000176	0.000361	CcSEcCtD
Hydromorphone—Insomnia—Doxorubicin—urinary bladder cancer	0.000175	0.000359	CcSEcCtD
Hydromorphone—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000174	0.000356	CcSEcCtD
Hydromorphone—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000173	0.000354	CcSEcCtD
Hydromorphone—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000172	0.000353	CcSEcCtD
Hydromorphone—Somnolence—Doxorubicin—urinary bladder cancer	0.000172	0.000353	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000171	0.00035	CcSEcCtD
Hydromorphone—Dyspepsia—Doxorubicin—urinary bladder cancer	0.00017	0.000349	CcSEcCtD
Hydromorphone—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000168	0.000345	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000167	0.000342	CcSEcCtD
Hydromorphone—Fatigue—Doxorubicin—urinary bladder cancer	0.000167	0.000342	CcSEcCtD
Hydromorphone—Urticaria—Epirubicin—urinary bladder cancer	0.000166	0.00034	CcSEcCtD
Hydromorphone—Constipation—Doxorubicin—urinary bladder cancer	0.000166	0.000339	CcSEcCtD
Hydromorphone—Pain—Doxorubicin—urinary bladder cancer	0.000166	0.000339	CcSEcCtD
Hydromorphone—Abdominal pain—Epirubicin—urinary bladder cancer	0.000165	0.000339	CcSEcCtD
Hydromorphone—Body temperature increased—Epirubicin—urinary bladder cancer	0.000165	0.000339	CcSEcCtD
Hydromorphone—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000165	0.000337	CcSEcCtD
Hydromorphone—Asthenia—Methotrexate—urinary bladder cancer	0.00016	0.000329	CcSEcCtD
Hydromorphone—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.00016	0.000327	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000158	0.000324	CcSEcCtD
Hydromorphone—Pruritus—Methotrexate—urinary bladder cancer	0.000158	0.000324	CcSEcCtD
Hydromorphone—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000154	0.000316	CcSEcCtD
Hydromorphone—Urticaria—Doxorubicin—urinary bladder cancer	0.000154	0.000315	CcSEcCtD
Hydromorphone—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000153	0.000313	CcSEcCtD
Hydromorphone—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000153	0.000313	CcSEcCtD
Hydromorphone—Diarrhoea—Methotrexate—urinary bladder cancer	0.000153	0.000313	CcSEcCtD
Hydromorphone—Asthenia—Epirubicin—urinary bladder cancer	0.00015	0.000308	CcSEcCtD
Hydromorphone—Pruritus—Epirubicin—urinary bladder cancer	0.000148	0.000303	CcSEcCtD
Hydromorphone—Dizziness—Methotrexate—urinary bladder cancer	0.000148	0.000303	CcSEcCtD
Hydromorphone—Diarrhoea—Epirubicin—urinary bladder cancer	0.000143	0.000293	CcSEcCtD
Hydromorphone—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000143	0.000292	CcSEcCtD
Hydromorphone—Vomiting—Methotrexate—urinary bladder cancer	0.000142	0.000291	CcSEcCtD
Hydromorphone—Rash—Methotrexate—urinary bladder cancer	0.000141	0.000289	CcSEcCtD
Hydromorphone—Dermatitis—Methotrexate—urinary bladder cancer	0.000141	0.000288	CcSEcCtD
Hydromorphone—Headache—Methotrexate—urinary bladder cancer	0.00014	0.000287	CcSEcCtD
Hydromorphone—Asthenia—Doxorubicin—urinary bladder cancer	0.000139	0.000285	CcSEcCtD
Hydromorphone—Dizziness—Epirubicin—urinary bladder cancer	0.000138	0.000283	CcSEcCtD
Hydromorphone—Pruritus—Doxorubicin—urinary bladder cancer	0.000137	0.000281	CcSEcCtD
Hydromorphone—Vomiting—Epirubicin—urinary bladder cancer	0.000133	0.000273	CcSEcCtD
Hydromorphone—Nausea—Methotrexate—urinary bladder cancer	0.000133	0.000272	CcSEcCtD
Hydromorphone—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000132	0.000271	CcSEcCtD
Hydromorphone—Rash—Epirubicin—urinary bladder cancer	0.000132	0.00027	CcSEcCtD
Hydromorphone—Dermatitis—Epirubicin—urinary bladder cancer	0.000132	0.00027	CcSEcCtD
Hydromorphone—Headache—Epirubicin—urinary bladder cancer	0.000131	0.000268	CcSEcCtD
Hydromorphone—UGT1A9—Metabolism—TYMP—urinary bladder cancer	0.00013	0.000701	CbGpPWpGaD
Hydromorphone—Dizziness—Doxorubicin—urinary bladder cancer	0.000128	0.000262	CcSEcCtD
Hydromorphone—OPRM1—Signaling Pathways—HDAC4—urinary bladder cancer	0.000127	0.000684	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—GLI1—urinary bladder cancer	0.000126	0.000678	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000125	0.000673	CbGpPWpGaD
Hydromorphone—Nausea—Epirubicin—urinary bladder cancer	0.000124	0.000255	CcSEcCtD
Hydromorphone—Vomiting—Doxorubicin—urinary bladder cancer	0.000123	0.000252	CcSEcCtD
Hydromorphone—Rash—Doxorubicin—urinary bladder cancer	0.000122	0.00025	CcSEcCtD
Hydromorphone—Dermatitis—Doxorubicin—urinary bladder cancer	0.000122	0.00025	CcSEcCtD
Hydromorphone—Headache—Doxorubicin—urinary bladder cancer	0.000121	0.000248	CcSEcCtD
Hydromorphone—UGT1A9—Metabolism—NAT2—urinary bladder cancer	0.000117	0.000634	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR ligand binding—CXCL8—urinary bladder cancer	0.000115	0.000623	CbGpPWpGaD
Hydromorphone—Nausea—Doxorubicin—urinary bladder cancer	0.000115	0.000236	CcSEcCtD
Hydromorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	0.000112	0.000606	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—GLI1—urinary bladder cancer	0.000106	0.000573	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.000106	0.000573	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—TYMP—urinary bladder cancer	0.000106	0.000571	CbGpPWpGaD
Hydromorphone—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	0.000104	0.000563	CbGpPWpGaD
Hydromorphone—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000103	0.000555	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000102	0.000549	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—RRM2—urinary bladder cancer	0.000101	0.000547	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR ligand binding—CXCL8—urinary bladder cancer	0.000101	0.000546	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—RBX1—urinary bladder cancer	9.81e-05	0.00053	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	9.77e-05	0.000527	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	9.68e-05	0.000523	CbGpPWpGaD
Hydromorphone—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	9.58e-05	0.000517	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—NAT2—urinary bladder cancer	9.57e-05	0.000517	CbGpPWpGaD
Hydromorphone—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	9.45e-05	0.00051	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—HPGDS—urinary bladder cancer	9.38e-05	0.000507	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—ENO2—urinary bladder cancer	9.38e-05	0.000507	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	9.33e-05	0.000504	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	9.26e-05	0.0005	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—NAT1—urinary bladder cancer	9.26e-05	0.0005	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—TSC1—urinary bladder cancer	9.23e-05	0.000498	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—NAT1—urinary bladder cancer	9.18e-05	0.000496	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	9.18e-05	0.000496	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—GSTT1—urinary bladder cancer	9.1e-05	0.000491	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	9.03e-05	0.000488	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	8.96e-05	0.000484	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—JAG1—urinary bladder cancer	8.78e-05	0.000474	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—RBX1—urinary bladder cancer	8.6e-05	0.000465	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR ligand binding—CXCL8—urinary bladder cancer	8.55e-05	0.000462	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	8.47e-05	0.000457	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	8.4e-05	0.000453	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—RRM2—urinary bladder cancer	8.26e-05	0.000446	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—TSC1—urinary bladder cancer	8.09e-05	0.000437	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—JAG1—urinary bladder cancer	7.7e-05	0.000416	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—ENO2—urinary bladder cancer	7.65e-05	0.000413	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—HPGDS—urinary bladder cancer	7.65e-05	0.000413	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	7.62e-05	0.000412	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	7.6e-05	0.000411	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—NQO1—urinary bladder cancer	7.56e-05	0.000408	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	7.56e-05	0.000408	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—RHOA—urinary bladder cancer	7.42e-05	0.000401	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—GSTT1—urinary bladder cancer	7.42e-05	0.000401	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	7.34e-05	0.000396	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	7.3e-05	0.000394	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—RBX1—urinary bladder cancer	7.27e-05	0.000393	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	7.2e-05	0.000389	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	7.14e-05	0.000385	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—S100B—urinary bladder cancer	7.11e-05	0.000384	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	7.02e-05	0.000379	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	6.96e-05	0.000376	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—TSC1—urinary bladder cancer	6.84e-05	0.000369	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—RHOA—urinary bladder cancer	6.74e-05	0.000364	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—CXCL8—urinary bladder cancer	6.52e-05	0.000352	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—RHOA—urinary bladder cancer	6.51e-05	0.000352	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—JAG1—urinary bladder cancer	6.51e-05	0.000352	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	6.4e-05	0.000346	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—NCOR1—urinary bladder cancer	6.4e-05	0.000345	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	6.39e-05	0.000345	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—GSTP1—urinary bladder cancer	6.31e-05	0.000341	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—S100B—urinary bladder cancer	6.24e-05	0.000337	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—IL2—urinary bladder cancer	6.23e-05	0.000336	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—NQO1—urinary bladder cancer	6.16e-05	0.000333	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	6.1e-05	0.00033	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	6.05e-05	0.000327	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—NAT1—urinary bladder cancer	6.05e-05	0.000327	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	5.98e-05	0.000323	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—CXCL8—urinary bladder cancer	5.92e-05	0.00032	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—RHOA—urinary bladder cancer	5.91e-05	0.000319	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—TYMS—urinary bladder cancer	5.86e-05	0.000317	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—NCOR1—urinary bladder cancer	5.8e-05	0.000313	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—GSTM1—urinary bladder cancer	5.8e-05	0.000313	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—CXCL8—urinary bladder cancer	5.72e-05	0.000309	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—IL2—urinary bladder cancer	5.66e-05	0.000305	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—TERT—urinary bladder cancer	5.64e-05	0.000304	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—TYMP—urinary bladder cancer	5.61e-05	0.000303	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—NCOR1—urinary bladder cancer	5.61e-05	0.000303	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	5.58e-05	0.000301	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—TYMP—urinary bladder cancer	5.56e-05	0.0003	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—GPX1—urinary bladder cancer	5.55e-05	0.0003	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	5.54e-05	0.000299	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—RHOA—urinary bladder cancer	5.5e-05	0.000297	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—IL2—urinary bladder cancer	5.46e-05	0.000295	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—ERCC2—urinary bladder cancer	5.45e-05	0.000294	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	5.34e-05	0.000288	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—S100B—urinary bladder cancer	5.27e-05	0.000285	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	5.22e-05	0.000282	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—CXCL8—urinary bladder cancer	5.19e-05	0.00028	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—FGFR3—urinary bladder cancer	5.17e-05	0.000279	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—GSTP1—urinary bladder cancer	5.14e-05	0.000278	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—MTHFR—urinary bladder cancer	5.12e-05	0.000277	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—NAT2—urinary bladder cancer	5.07e-05	0.000274	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—NAT2—urinary bladder cancer	5.03e-05	0.000272	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—ESR1—urinary bladder cancer	5.02e-05	0.000271	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—RHOA—urinary bladder cancer	5e-05	0.00027	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	4.99e-05	0.000269	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	4.97e-05	0.000269	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—IL2—urinary bladder cancer	4.96e-05	0.000268	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—TERT—urinary bladder cancer	4.94e-05	0.000267	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—CXCL8—urinary bladder cancer	4.83e-05	0.000261	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—TYMS—urinary bladder cancer	4.78e-05	0.000258	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—NCOR1—urinary bladder cancer	4.74e-05	0.000256	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—GSTM1—urinary bladder cancer	4.72e-05	0.000255	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—NCOR1—urinary bladder cancer	4.72e-05	0.000255	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	4.71e-05	0.000254	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—IL2—urinary bladder cancer	4.62e-05	0.000249	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	4.59e-05	0.000248	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—FGFR3—urinary bladder cancer	4.54e-05	0.000245	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—GPX1—urinary bladder cancer	4.52e-05	0.000244	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—ERCC2—urinary bladder cancer	4.44e-05	0.00024	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—ESR1—urinary bladder cancer	4.4e-05	0.000238	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CREBBP—urinary bladder cancer	4.4e-05	0.000238	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—CXCL8—urinary bladder cancer	4.39e-05	0.000237	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—RRM2—urinary bladder cancer	4.38e-05	0.000236	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—IGF1—urinary bladder cancer	4.35e-05	0.000235	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—RRM2—urinary bladder cancer	4.34e-05	0.000234	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—EGFR—urinary bladder cancer	4.33e-05	0.000234	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—IL2—urinary bladder cancer	4.19e-05	0.000226	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—TERT—urinary bladder cancer	4.18e-05	0.000226	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—MTHFR—urinary bladder cancer	4.18e-05	0.000226	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PPARG—urinary bladder cancer	4.15e-05	0.000224	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—KRAS—urinary bladder cancer	4.09e-05	0.000221	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	4.06e-05	0.000219	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ENO2—urinary bladder cancer	4.06e-05	0.000219	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	4.02e-05	0.000217	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ENO2—urinary bladder cancer	4.02e-05	0.000217	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4e-05	0.000216	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—CREBBP—urinary bladder cancer	3.99e-05	0.000215	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—RHOA—urinary bladder cancer	3.98e-05	0.000215	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	3.93e-05	0.000212	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	3.9e-05	0.000211	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CREBBP—urinary bladder cancer	3.86e-05	0.000208	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.84e-05	0.000207	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—FGFR3—urinary bladder cancer	3.83e-05	0.000207	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—IGF1—urinary bladder cancer	3.81e-05	0.000206	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—EGFR—urinary bladder cancer	3.79e-05	0.000205	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—ESR1—urinary bladder cancer	3.72e-05	0.000201	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—ERBB2—urinary bladder cancer	3.69e-05	0.000199	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—TYMP—urinary bladder cancer	3.67e-05	0.000198	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—KRAS—urinary bladder cancer	3.58e-05	0.000194	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CXCL8—urinary bladder cancer	3.5e-05	0.000189	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—RHOA—urinary bladder cancer	3.49e-05	0.000189	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—HRAS—urinary bladder cancer	3.47e-05	0.000188	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PPARG—urinary bladder cancer	3.39e-05	0.000183	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—IL2—urinary bladder cancer	3.34e-05	0.00018	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—NAT2—urinary bladder cancer	3.32e-05	0.000179	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—NQO1—urinary bladder cancer	3.27e-05	0.000177	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PTGS2—urinary bladder cancer	3.27e-05	0.000176	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CREBBP—urinary bladder cancer	3.26e-05	0.000176	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CCND1—urinary bladder cancer	3.26e-05	0.000176	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—CREBBP—urinary bladder cancer	3.25e-05	0.000176	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—NQO1—urinary bladder cancer	3.24e-05	0.000175	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—ERBB2—urinary bladder cancer	3.23e-05	0.000175	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—IGF1—urinary bladder cancer	3.22e-05	0.000174	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—EGFR—urinary bladder cancer	3.21e-05	0.000173	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—MMP9—urinary bladder cancer	3.16e-05	0.000171	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CDKN1A—urinary bladder cancer	3.15e-05	0.00017	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.14e-05	0.00017	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—PTEN—urinary bladder cancer	3.14e-05	0.00017	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CXCL8—urinary bladder cancer	3.07e-05	0.000166	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—HRAS—urinary bladder cancer	3.05e-05	0.000165	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—KRAS—urinary bladder cancer	3.03e-05	0.000164	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—EP300—urinary bladder cancer	3e-05	0.000162	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—RHOA—urinary bladder cancer	2.95e-05	0.000159	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—IL2—urinary bladder cancer	2.93e-05	0.000158	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—SRC—urinary bladder cancer	2.92e-05	0.000157	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—RRM2—urinary bladder cancer	2.86e-05	0.000155	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CCND1—urinary bladder cancer	2.86e-05	0.000154	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PTEN—urinary bladder cancer	2.85e-05	0.000154	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—MMP9—urinary bladder cancer	2.77e-05	0.00015	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CDKN1A—urinary bladder cancer	2.76e-05	0.000149	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—PTEN—urinary bladder cancer	2.76e-05	0.000149	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.74e-05	0.000148	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—ERBB2—urinary bladder cancer	2.73e-05	0.000148	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	2.73e-05	0.000147	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—EP300—urinary bladder cancer	2.72e-05	0.000147	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	2.7e-05	0.000146	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PTGS2—urinary bladder cancer	2.66e-05	0.000144	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ENO2—urinary bladder cancer	2.65e-05	0.000143	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	2.65e-05	0.000143	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—EP300—urinary bladder cancer	2.63e-05	0.000142	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.62e-05	0.000141	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—MYC—urinary bladder cancer	2.61e-05	0.000141	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CXCL8—urinary bladder cancer	2.59e-05	0.00014	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—HRAS—urinary bladder cancer	2.57e-05	0.000139	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	2.57e-05	0.000139	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—SRC—urinary bladder cancer	2.56e-05	0.000138	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—EGFR—urinary bladder cancer	2.56e-05	0.000138	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—TYMS—urinary bladder cancer	2.53e-05	0.000137	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—TYMS—urinary bladder cancer	2.51e-05	0.000136	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	2.51e-05	0.000135	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	2.51e-05	0.000135	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	2.48e-05	0.000134	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	2.48e-05	0.000134	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—IL2—urinary bladder cancer	2.48e-05	0.000134	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—KRAS—urinary bladder cancer	2.41e-05	0.00013	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CCND1—urinary bladder cancer	2.41e-05	0.00013	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GPX1—urinary bladder cancer	2.4e-05	0.00013	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GPX1—urinary bladder cancer	2.38e-05	0.000128	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	2.36e-05	0.000127	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MMP9—urinary bladder cancer	2.34e-05	0.000127	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	2.34e-05	0.000126	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CDKN1A—urinary bladder cancer	2.34e-05	0.000126	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PTEN—urinary bladder cancer	2.33e-05	0.000126	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PTEN—urinary bladder cancer	2.32e-05	0.000125	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—MYC—urinary bladder cancer	2.29e-05	0.000124	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—EGFR—urinary bladder cancer	2.24e-05	0.000121	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—EP300—urinary bladder cancer	2.22e-05	0.00012	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—EP300—urinary bladder cancer	2.22e-05	0.00012	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	2.21e-05	0.00012	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	2.2e-05	0.000119	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—SRC—urinary bladder cancer	2.16e-05	0.000117	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—TP53—urinary bladder cancer	2.15e-05	0.000116	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—NQO1—urinary bladder cancer	2.14e-05	0.000115	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—KRAS—urinary bladder cancer	2.12e-05	0.000114	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—HRAS—urinary bladder cancer	2.05e-05	0.000111	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MYC—urinary bladder cancer	1.94e-05	0.000105	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—EGFR—urinary bladder cancer	1.89e-05	0.000102	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—TP53—urinary bladder cancer	1.88e-05	0.000102	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—HRAS—urinary bladder cancer	1.8e-05	9.72e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PPARG—urinary bladder cancer	1.8e-05	9.7e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—KRAS—urinary bladder cancer	1.79e-05	9.66e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.78e-05	9.63e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PPARG—urinary bladder cancer	1.78e-05	9.61e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	1.72e-05	9.32e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	1.71e-05	9.23e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.66e-05	8.95e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.64e-05	8.85e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.64e-05	8.85e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—TP53—urinary bladder cancer	1.59e-05	8.59e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.57e-05	8.47e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.54e-05	8.32e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—HRAS—urinary bladder cancer	1.52e-05	8.21e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.45e-05	7.82e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	1.41e-05	7.63e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	1.4e-05	7.56e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PTEN—urinary bladder cancer	1.23e-05	6.65e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PTEN—urinary bladder cancer	1.22e-05	6.6e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—EP300—urinary bladder cancer	1.17e-05	6.34e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.17e-05	6.34e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—EP300—urinary bladder cancer	1.16e-05	6.29e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.13e-05	6.09e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	9.24e-06	4.99e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PTEN—urinary bladder cancer	8.05e-06	4.35e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—EP300—urinary bladder cancer	7.68e-06	4.15e-05	CbGpPWpGaD
